C-reactive protein levels after cardiac arrest in patients treated with therapeutic hypothermia

Antonio Maria Dell'anna1, Julia Bini Viotti1, Marjorie Beumier1

  • 1Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik, 808, 1070 Brussels, Belgium.

Resuscitation
|April 22, 2014
PubMed

Insights

High C-reactive protein (CRP) levels after cardiac arrest (CA) indicate a greater inflammatory response. Elevated admission CRP levels are linked to poor neurological outcomes, suggesting CRP as a potential therapeutic target.

Area of Science:

  • Critical Care Medicine
  • Biomarkers
  • Inflammation Research

Background:

  • Prognostication after cardiac arrest (CA) remains challenging.
  • C-reactive protein (CRP) is an accessible inflammatory biomarker.
  • Assessing CRP's prognostic value post-CA is crucial.

Purpose of the Study:

  • To evaluate the prognostic significance of daily C-reactive protein (CRP) levels in patients following cardiac arrest (CA).
  • To determine if CRP levels can predict neurological outcome at three months post-CA.

Main Methods:

  • Retrospective review of 130 intensive care unit (ICU) patients surviving >24h after CA (Jan 2009-Dec 2011).
  • Collected demographic and CA data, including initial rhythm and return of spontaneous circulation (ROSC).
  • Measured daily CRP levels from admission to day 3; assessed neurological outcome at 3 months (Cerebral Performance Category [CPC] 1-5).

Main Results:

  • Overall mortality was 56%; 58% developed infection.
  • CRP levels increased from admission to day 3.
  • Higher admission CRP levels were observed in in-hospital CA, non-shockable rhythms, and patients with infection (p<0.001).
  • High admission CRP levels were independently associated with poor neurological outcome (CPC 3-5) at 3 months.

Conclusions:

  • CRP levels rise post-resuscitation, reflecting inflammatory response.
  • Elevated CRP is associated with in-hospital CA, non-shockable rhythms, and infection.
  • Admission CRP levels may identify high-risk patients for poor neurological outcomes, indicating potential therapeutic targets.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K